Beijing Tongrentang Co.Ltd(600085) the hot discussion on the price rise of Angong Niuhuang has not completely subsided, and another Chinese medicine Giant China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) announced that the price of Angong Niuhuang Pill has been raised.
More than half a year ago, Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) also raised the product price. several pharmaceutical enterprises attribute the price rise of raw materials to the main reason for the price rise of products.
It is not known whether traditional Chinese medicine enterprises will usher in the price rise tide, but from the financial data, from Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) to Beijing Tongrentang Co.Ltd(600085) and then to China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) are faced with performance pressure of different degrees .
leading traditional Chinese medicine enterprises have raised prices
On December 13, China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) responded to investors’ questions on the interactive platform and said that the ex factory price of China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) Angong Niuhuang Pill has increased this year.
Perhaps the name China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) is not well known to everyone, but you must know that “Sanjiu Ganmaoling”, “Sanjiu Weitai” and “999” series drugs can be said to be the standing medicine of every Chinese family.
For the reasons for the price increase of Angong Niuhuang Pill, China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) said that with the increase of the overall cost in recent years, especially the rising cost of raw materials and manpower, while taking into account the acceptance ability of patients and the company’s ability to alleviate the cost pressure, the company will also adopt different pricing strategies for different products and different stages of the product cycle.
It is understood that Angong Niuhuang Pill is derived from the identification of febrile diseases in the Qing Dynasty. It is composed of more than a dozen drugs such as bezoar, rhinoceros horn, musk and cinnabar to treat high fever, irritability, stroke and coma.
The reporter inquired about the price information of tiandi.com, a Chinese herbal medicine. Taking the raw material bezoar as an example, the price of natural bezoar has increased significantly in recent years, from 210000 yuan five years ago to 520000 yuan in 2021 .
Angong Niuhuang Pill is not the exclusive variety of China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) . According to the official website of the State Food and drug administration, there are 120 product registration information related to Angong Niuhuang pills. The manufacturers include Sunflower Pharmaceutical Group Co.Ltd(002737) , Harbin Pharmaceutical Group, Tianjin Zhongxin Pharmaceutical Group Corporation Limited(600329) and Beijing Tongrentang Co.Ltd(600085) .
Not long ago, Beijing Tongrentang Co.Ltd(600085) also adjusted the price of its Angong Niuhuang Pill, its Angong Niuhuang Pill (3G × The sales price of 1 pill / box) was raised from 780 yuan to 860 yuan, with a price increase of about 10% , which began to be implemented on December 1. The staff of Beijing Beijing Tongrentang Co.Ltd(600085) drugstore told reporters that the main reason for the price increase was the rising cost of raw materials. At present, online e-commerce platforms have implemented the above prices.
The reporter contacted China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) about the range of product price increase, but as of press time, no reply had been received. On the e-commerce platform, China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) Angong Niuhuang Pill has different prices. The price of Sanjiu Angong Niuhuang Pill in Ali health pharmacy is 399 yuan (3G) × 1 pill / box), the price in the flagship store of Zhongde pharmacy is 360 yuan (3G) × 1 pill / box), the price of houchuan pharmacy is 368 yuan (3G) × 1 pill / box).
The customer service of the above pharmacy told the Beijing Business Daily that when the price of drugs rises, the store will rise with the price, and the price is determined by the market.
performance pressure
The rise in raw material prices is attributed to the main reason for the rise in product prices by the above-mentioned enterprises, but it is worth mentioning that behind the rise in prices, enterprises are also facing varying degrees of performance pressure .
As one of the time-honored brands of traditional Chinese medicine, Beijing Tongrentang Co.Ltd(600085) mainly focuses on cardio cerebrovascular products, tonic products, heat clearing products, gynecology and other products. among them, Angong Niuhuang Pill belongs to cardiovascular and cerebrovascular products. This plate contributed a revenue of 3.004 billion yuan to Beijing Tongrentang Co.Ltd(600085) in 2020, ranking first among the five plates.
However, the decline of the plate has become more and more obvious in recent years. In 2020, the revenue of Beijing Tongrentang Co.Ltd(600085) cardiovascular and cerebrovascular products decreased by 1.16% year-on-year. In terms of overall performance, from 2018 to 2020, Beijing Tongrentang Co.Ltd(600085) achieved revenue of 14.21 billion yuan, 13.28 billion yuan and 12.83 billion yuan respectively, with revenue growth rates of 6.23%, – 6.56% and – 3.4% respectively; The net profit was 1.134 billion yuan, 985 million yuan and 1.031 billion yuan respectively, and the net profit growth rate was 11.49%, – 13.12% and 4.67%.
According to the financial report for the third quarter of 2021 disclosed by China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) , the company achieved an operating revenue of 3.343 billion yuan, a year-on-year decrease of 2.7%; The net profit was 376 million yuan, a year-on-year decrease of 28.57%. China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) said on the investor interaction platform that the reason for the year-on-year decline in the company’s revenue and profit was mainly affected by the rapid decline in the anti infection business in the prescription drug business and a certain decline in traditional Chinese medicine injections.
In the field of traditional Chinese medicine, there are Beijing Tongrentang Co.Ltd(600085) in the north and Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) in the south. in May this year, the product Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) containing bezoar and musk also raised the product price on the grounds of rising cost and price, and sold it in the form of limited supply.
The price increase has stabilized the performance of Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) to a certain extent. At present, the core products of Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) include Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) , Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) capsules and Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) series products such as compound Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) buccal tablets and compound Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) ointment. Among them, liver disease drug business is Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) the main source of revenue and the business segment with the largest gross profit margin.
According to the financial report data, from 2017 to 2020, Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) ‘s revenue growth of liver disease drugs was 35.48%, 32.07%, 21.37% and 16.44% respectively, gradually slowing down. Over the same period, the overall performance growth of Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) was 60.85%, 28.33%, 20.06% and 13.78% respectively.
Li Xu, an investor in the pharmaceutical industry, told the Beijing Business Daily that traditional Chinese medicine products will rise due to the rising price of raw materials. Before new products are available or new pillar products appear, price increase is the easiest way for enterprises to stabilize their performance. After the news of price increase, as of the closing on December 13, 2021, China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) shares rose 0.35%.
860 yuan a box of traditional Chinese medicine becomes a luxury? Beijing Tongrentang Co.Ltd(600085) “divine medicine” Angong Niuhuang Pill increased by another 10%! Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) follow or not?
Beijing Tongrentang Co.Ltd(600085) the price of Angong Niuhuang Pill increased by 10% Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) did not follow the trend, but “reservation required”
China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) : the ex factory price of Angong Niuhuang Pill has increased this year
(Beijing business daily)
